Medical Specialties Industry Financials, Performance and Ratios
-
Industry Score
40.5 /100
Rank 52 out of 131 Industries -
Advance/Decline
101/108
-
No. of Companies209
-
Avg. Market Cap8,964
-
Price to Earning Ratio34.97
-
Price to Earning Growth Ratio14.98
-
Price to Book Ratio39.58
-
Return on Equity10.85
-
Return on Capital Employed-
-
Return on Assets5.72
-
Dividend yield 1 year %0.20 %
-
Net Profit Growth Annual YoY %-5.34 %
-
Net Profit Growth Qtr YoY %26.83 %
-
Net Profit Growth Qtr QoQ %17.71 %
Show more
*All values are market cap weighted averages.
*All Financial parameters are in Million USD.
Medical Specialties Industry Market Breadth
- < -5%
- -2 to -5%
- 0 to -2%
- 0 to 2%
- 2 to 5%
- > 5%
Medical Specialties Peer comparison
Compare all stocks in Medical Specialties industry listed on stock exchanges
| Stock Name | 3M Price Chart | Market Cap | LTPLast Traded Price | Day High Low (%) | Week High Low (%) | Month High Low (%) | Qtr High Low(%) | 1 Year High low(%) | 3 Year High low(%) | 5 Year High low(%) | 10 Year High low(%) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Agilent Tech |
|
41,949.6
|
148.5
|
L
 -0.5%
H
147.3
149.5
|
L
 1.8%
H
145.5
150.2
|
L
 9.9%
H
125
150.2
|
L
 31.1%
H
108.4
150.2
|
L
 25.0%
H
108.4
160.3
|
L
 17.3%
H
96.4
160.3
|
L
 -6.7%
H
96.4
179.6
|
L
 208.5%
H
42.9
179.6
|
| Abbott |
|
192,505.1
|
111.3
|
L
 0.0%
H
110.8
112.0
|
L
 3.2%
H
107.4
112.5
|
L
 26.0%
H
87.6
112.5
|
L
 31.0%
H
84.1
112.5
|
L
 -14.0%
H
82.0
137.5
|
L
 4.9%
H
82.0
141.2
|
L
 -9.6%
H
82.0
142.6
|
L
 147.0%
H
37.4
142.6
|
| Alcon Inc - Registered Shares |
|
35,892.5
|
74.3
|
L
 1.0%
H
74.0
74.9
|
L
 3.4%
H
71.2
76.2
|
L
 11.1%
H
66.2
76.2
|
L
 16.0%
H
63.6
76.2
|
L
 -14.5%
H
61.8
90.4
|
L
 -8.9%
H
61.8
101.1
|
L
 5.9%
H
55.2
101.1
|
L
H
39.4
101.1
|
| Artivion Inc |
|
1,420.8
|
29.1
|
L
 2.6%
H
28.3
29.2
|
L
 7.5%
H
26.2
29.3
|
L
 26.0%
H
23.2
29.3
|
L
 27.1%
H
19.8
29.3
|
L
 -32.2%
H
19.2
48.3
|
L
 69.7%
H
12.2
48.3
|
L
 15.9%
H
9.6
48.3
|
L
 87.9%
H
9.6
48.3
|
| Avantor Inc |
|
9,239.1
|
13.7
|
L
 -1.4%
H
13.6
13.8
|
L
 0.5%
H
13.4
14.0
|
L
 21.0%
H
10.2
14.6
|
L
 72.0%
H
7.4
14.6
|
L
 5.2%
H
7.3
15.9
|
L
 -35.3%
H
7.3
28
|
L
 -64.6%
H
7.3
44.4
|
L
H
6.7
44.4
|
| Baxter International |
|
13,819.3
|
26.7
|
L
 -1.2%
H
26.6
27.2
|
L
 -3.0%
H
26.6
28.0
|
L
 22.6%
H
21.4
30
|
L
 50.3%
H
17.2
30
|
L
 9.3%
H
15.7
30
|
L
 -37.6%
H
15.7
44
|
L
 -64.1%
H
15.7
89.7
|
L
 -45.0%
H
15.7
95.2
|
| Becton, Dickinson and Co. |
|
49,955.7
|
183.4
|
L
 0.8%
H
181.2
183.8
|
L
 3.7%
H
175.6
185.3
|
L
 21.7%
H
150.4
185.3
|
L
 27.0%
H
140.1
185.3
|
L
 -6.0%
H
140.1
213.1
|
L
 -35.1%
H
140.1
283.5
|
L
 -23.8%
H
140.1
287.3
|
L
 8.0%
H
140.1
287.3
|
| Butterfly Network Inc (Class A) |
|
2,354.0
|
8.8
|
L
 -0.2%
H
8.4
8.9
|
L
 0.1%
H
8.4
10.1
|
L
 14.1%
H
6.4
10.1
|
L
 115.6%
H
3.8
10.1
|
L
 527.0%
H
1.3
10.1
|
L
 353.3%
H
0.7
10.1
|
L
 -17.5%
H
0.7
13.6
|
L
H
0.7
29.1
|
| Bio-Rad Laboratories Inc (Class A) |
|
9,525.7
|
356.3
|
L
 -1.4%
H
355.1
362.5
|
L
 1.1%
H
347.9
365
|
L
 19.4%
H
285.4
365
|
L
 44.7%
H
242.8
365
|
L
 24.0%
H
236.7
365
|
L
 -9.8%
H
211.4
406.4
|
L
 -54.2%
H
211.4
832.7
|
L
 131.4%
H
147.7
832.7
|
| Bausch + Lomb Corp |
|
6,089.7
|
17.1
|
L
 0.4%
H
16.9
17.2
|
L
 1.6%
H
16.3
17.2
|
L
 6.8%
H
15.6
17.2
|
L
 4.8%
H
14.7
17.5
|
L
 21.1%
H
13.8
18.9
|
L
 -9.6%
H
10.5
21.7
|
L
H
10.5
22.0
|
L
H
10.5
22.0
|
| Boston Scientific |
|
75,113.6
|
51.8
|
L
 0.3%
H
51.7
53.0
|
L
 5.1%
H
49.5
53.0
|
L
 21.6%
H
42.2
53.0
|
L
 -3.2%
H
42.2
58.5
|
L
 -50.2%
H
42.2
109.5
|
L
 1.0%
H
42.2
109.5
|
L
 16.9%
H
35.0
109.5
|
L
 117.0%
H
19.7
109.5
|
| Conmed Corp |
|
1,509.8
|
50.4
|
L
 1.2%
H
49.1
50.6
|
L
 2.6%
H
48.4
50.6
|
L
 20.7%
H
41.0
53.7
|
L
 38.7%
H
31.4
53.7
|
L
 -4.2%
H
31.4
56.6
|
L
 -55.9%
H
31.4
117.3
|
L
 -59.2%
H
31.4
159.1
|
L
 30.3%
H
31.4
159.1
|
| Cooper Companies |
|
14,855.5
|
76.2
|
L
 -0.6%
H
76.1
76.9
|
L
 2.6%
H
74.2
77.6
|
L
 11.2%
H
68.6
77.6
|
L
 26.2%
H
59.1
77.6
|
L
 3.7%
H
58.9
89.8
|
L
 -19.4%
H
58.9
112.4
|
L
 -30.3%
H
58.9
115.9
|
L
 68.5%
H
39.7
115.9
|
| Danaher |
|
142,319.5
|
202.5
|
L
 -0.7%
H
201.1
204.0
|
L
 -1.1%
H
200.8
209.4
|
L
 1.7%
H
165.8
209.9
|
L
 23.0%
H
160.9
209.9
|
L
 -3.7%
H
160.9
242.8
|
L
 -21.3%
H
160.9
281.7
|
L
 -35.8%
H
160.9
334.0
|
L
 148.7%
H
75.7
334.0
|
| Enovis Corp |
|
1,502.9
|
26.1
|
L
 1.6%
H
25.8
26.4
|
L
 -2.1%
H
23.6
26.6
|
L
 5.7%
H
23.6
31.7
|
L
 -0.2%
H
19.1
31.7
|
L
 -9.6%
H
19.1
34.3
|
L
 -53.9%
H
19.1
65.0
|
L
H
19.1
72.1
|
L
H
19.1
72.1
|
| Edwards Lifesciences |
|
52,798.2
|
91.6
|
L
 -1.0%
H
91.5
92.9
|
L
 2.1%
H
88.6
93.9
|
L
 1.7%
H
81.2
93.9
|
L
 12.6%
H
80.1
96.3
|
L
 17.2%
H
72.3
96.3
|
L
 13.7%
H
58.9
96.3
|
L
 -19.0%
H
58.9
131.7
|
L
 141.9%
H
27.0
131.7
|
| Glaukos Corp |
|
10,884.3
|
184.5
|
L
 -2.6%
H
184.2
190
|
L
 2.5%
H
177.6
190
|
L
 21.0%
H
145.8
190
|
L
 29.8%
H
99.5
190
|
L
 102.6%
H
73.2
190
|
L
 150.0%
H
59.2
190
|
L
 276.9%
H
33.3
190
|
L
 447.2%
H
23.1
190
|
| Globus Medical Inc (Class A) |
|
11,533.1
|
85.9
|
L
 -0.1%
H
84.7
86.4
|
L
 4.3%
H
81.4
86.9
|
L
 13.3%
H
74.5
88.1
|
L
 11.3%
H
74.4
88.1
|
L
 43.1%
H
54.2
101.4
|
L
 49.4%
H
43.4
101.4
|
L
 12.4%
H
43.4
101.4
|
L
 273.2%
H
19.3
101.4
|
| Haemonetics Corp |
|
4,131.1
|
90.8
|
L
 0.5%
H
89.8
91.5
|
L
 3.4%
H
86.0
92.3
|
L
 22.0%
H
74.4
92.3
|
L
 59.0%
H
55.8
92.3
|
L
 73.5%
H
47.3
92.3
|
L
 -2.1%
H
47.3
98.0
|
L
 48.5%
H
43.5
98.0
|
L
 150.5%
H
32.8
142.1
|
| Inspire Medical Systems Inc |
|
1,650.8
|
57.1
|
L
 -1.9%
H
57.0
58.1
|
L
 -5.1%
H
57.0
61.3
|
L
 16.2%
H
48.2
66.2
|
L
 33.9%
H
38.9
66.2
|
L
 -32.5%
H
38.9
147.0
|
L
 -77.3%
H
38.9
257.4
|
L
 -69.7%
H
38.9
330
|
L
H
22.5
330
|
| Integer Holdings Corp |
|
4,257.8
|
125.3
|
L
 0.2%
H
125.1
125.4
|
L
 0.0%
H
124.9
125.4
|
L
 34.2%
H
93.5
126.1
|
L
 39.5%
H
87.0
126.1
|
L
 17.3%
H
62
126.1
|
L
 39.6%
H
62
146.4
|
L
 36.4%
H
50.1
146.4
|
L
 446.5%
H
18.1
146.4
|
| Medtronic |
|
116,829.7
|
91.3
|
L
 0.8%
H
90.4
92.0
|
L
 4.7%
H
86.7
92.0
|
L
 15.1%
H
79.5
92.0
|
L
 18.6%
H
73.3
92.0
|
L
 -0.8%
H
73.3
106.3
|
L
 9.8%
H
68.9
106.3
|
L
 -28.9%
H
68.9
135.9
|
L
 4.3%
H
68.9
135.9
|
| Mettler-Toledo International |
|
28,432.3
|
1,419.0
|
L
 -0.8%
H
1402.6
1423.9
|
L
 -0.7%
H
1402.6
1446.2
|
L
 7.9%
H
1216.9
1474.2
|
L
 36.2%
H
1027.7
1474.2
|
L
 8.0%
H
1023.1
1525.2
|
L
 14.4%
H
928.5
1546.9
|
L
 -7.7%
H
928.5
1714.8
|
L
 254.8%
H
386.0
1714.8
|
| Envista Holdings Corp |
|
4,508.5
|
28.1
|
L
 0.0%
H
27.9
28.4
|
L
 -0.3%
H
27.6
29
|
L
 7.5%
H
25.8
29
|
L
 17.6%
H
22.4
29
|
L
 34.8%
H
18.8
30.4
|
L
 -15.7%
H
14.2
33.3
|
L
 -29.8%
H
14.2
52.0
|
L
H
10.1
52.0
|
| Owens & Minor Inc |
|
73.1
|
1.0
|
L
 -13.6%
H
0.9
1.1
|
L
 -66.1%
H
0.9
1.7
|
L
 -73.7%
H
0.9
3.8
|
L
 -68.8%
H
0.9
3.8
|
L
 -82.4%
H
0.9
5.9
|
L
 -95.2%
H
0.9
28.4
|
L
 -97.5%
H
0.9
49.1
|
L
 -97.2%
H
0.9
49.2
|
| Penumbra Inc |
|
12,881.1
|
327.0
|
L
 0.1%
H
326.7
328.1
|
L
 0.7%
H
324.9
328.1
|
L
 3.4%
H
315.7
328.1
|
L
 1.3%
H
314.8
329.7
|
L
 29.2%
H
221.3
362.4
|
L
 27.9%
H
148
362.4
|
L
 26.9%
H
114.9
362.4
|
L
 340.1%
H
56.1
362.4
|
| Perkinelmer Inc |
|
-
|
116.8
|
L
 -0.6%
H
115.7
117.7
|
L
 1.9%
H
112.7
118.3
|
L
 5.1%
H
102.4
118.3
|
L
 21.2%
H
93.0
118.3
|
L
 30.6%
H
81.2
118.3
|
L
 25.3%
H
81.2
118.3
|
L
 -36.2%
H
81.2
201.1
|
L
 114.7%
H
45.4
201.1
|
| Qiagen NV |
|
8,869.0
|
43.0
|
L
 -0.7%
H
42.8
43.7
|
L
 1.5%
H
42.1
44.4
|
L
 3.3%
H
39.4
44.4
|
L
 29.0%
H
32.9
44.4
|
L
 -16.7%
H
32.5
57.8
|
L
 -12.7%
H
32.5
57.8
|
L
 -24.8%
H
32.5
64.7
|
L
 36.1%
H
27.8
65.9
|
| ResMed |
|
32,378.9
|
224.5
|
L
 -1.0%
H
223.8
228.6
|
L
 5.9%
H
210.6
228.6
|
L
 16.3%
H
190.2
228.6
|
L
 10.9%
H
180.3
228.6
|
L
 -21.2%
H
180.3
293.8
|
L
 24.1%
H
132.2
293.8
|
L
 -18.4%
H
132.2
301.3
|
L
 218.7%
H
56.6
301.3
|
| Silvergate Cap Corp (Class A) |
|
431.6
|
20.7
|
L
 7.8%
H
18.9
21.0
|
L
 0.7%
H
18.7
21.3
|
L
 -4.0%
H
18.7
24.6
|
L
 33.0%
H
13.5
24.6
|
L
 50.7%
H
10.9
24.6
|
L
 38.2%
H
10.9
24.6
|
L
 -81.4%
H
0.0
239.3
|
L
 5.2%
H
0.0
239.3
|
| Steris PLC |
|
22,744.8
|
233.3
|
L
 -1.2%
H
232.4
238.2
|
L
 -1.8%
H
232.4
241.4
|
L
 11.8%
H
208.5
241.4
|
L
 8.0%
H
198.0
241.4
|
L
 -5.2%
H
195.1
269.4
|
L
 1.8%
H
195.1
269.4
|
L
 6.6%
H
159.2
269.4
|
L
 227.5%
H
63.8
269.4
|
| Stevanato Grp Spa |
|
5,752.0
|
21.1
|
L
 -2.1%
H
21.0
21.6
|
L
 3.9%
H
20.0
21.6
|
L
 6.3%
H
18.7
21.6
|
L
 17.1%
H
16.3
21.6
|
L
 -5.0%
H
12.9
28
|
L
 -32.7%
H
12.9
35.6
|
L
 1.7%
H
12.9
36.3
|
L
H
12.9
36.3
|
| Stryker |
|
130,111.8
|
339.2
|
L
 -0.6%
H
335.1
341.5
|
L
 0.1%
H
335
349.8
|
L
 9.1%
H
306.9
352.5
|
L
 11.0%
H
291.0
352.5
|
L
 -10.4%
H
281
396.9
|
L
 19.1%
H
250.0
406.2
|
L
 28.9%
H
188.8
406.2
|
L
 193.5%
H
106.5
406.2
|
| Smith & Nephew PLC (ADR) |
|
12,475.7
|
29.8
|
L
 -1%
H
29.6
29.9
|
L
 -1%
H
29.5
30.3
|
L
 -0.1%
H
29.5
32.9
|
L
 0.3%
H
28.6
32.9
|
L
 -18.6%
H
28.6
38.8
|
L
 6.3%
H
21.5
38.8
|
L
 -22.0%
H
21.5
39.2
|
L
 -11.4%
H
21.5
52.3
|
| Teleflex Incorporated |
|
5,812.2
|
137.2
|
L
 0.1%
H
135.7
138
|
L
 1.6%
H
132.1
138
|
L
 5.4%
H
129.9
145
|
L
 5.3%
H
120.9
145
|
L
 13.2%
H
100.2
145
|
L
 -39.8%
H
100.2
257.9
|
L
 -62.5%
H
100.2
405.9
|
L
 -24.4%
H
100.2
449.4
|
| Thermo Fisher |
|
217,518.6
|
588.3
|
L
 -1.3%
H
587.5
594.7
|
L
 -1.0%
H
587.5
606.8
|
L
 10.2%
H
495.0
606.8
|
L
 31.3%
H
435.3
606.8
|
L
 21.3%
H
435.3
644.0
|
L
 8.9%
H
385.5
644.0
|
L
 8.0%
H
385.5
672.3
|
L
 278.3%
H
139.1
672.3
|
| Waters |
|
40,494.9
|
412.2
|
L
 -0.3%
H
408.7
415.8
|
L
 1.3%
H
402.6
420.3
|
L
 9.5%
H
345.2
420.3
|
L
 23.7%
H
323.9
420.3
|
L
 40.4%
H
282.8
420.3
|
L
 42.9%
H
231.9
423.6
|
L
 1.7%
H
231.9
428.2
|
L
 160.5%
H
133.4
428.2
|
| West Pharma Services |
|
24,590.7
|
349.4
|
L
 0.9%
H
343.5
349.5
|
L
 -1.3%
H
343.5
358.7
|
L
 -2.3%
H
325.3
386
|
L
 16.4%
H
296.8
386
|
L
 41.9%
H
223.8
386
|
L
 -12.6%
H
187.4
415.7
|
L
 -19.5%
H
187.4
475.4
|
L
 331.4%
H
70.2
475.4
|
| Zimmer Biomet Holdings |
|
19,197.7
|
100.7
|
L
 1.1%
H
99.0
101.2
|
L
 4.3%
H
94.3
101.2
|
L
 10.6%
H
87.9
101.8
|
L
 21.8%
H
81.6
101.8
|
L
 -1.4%
H
79.1
108.3
|
L
 -18.6%
H
79.1
133.9
|
L
 -26.8%
H
79.1
149.3
|
L
 -17.3%
H
70.0
169.7
|
| BioRad Laboratories Inc |
|
9,701.9
|
337
|
L
H
337
337
|
L
H
|
L
 8.9%
H
337
337
|
L
 29.6%
H
253.1
337
|
L
 36.4%
H
244.5
337
|
L
 1.4%
H
225.3
373.4
|
L
 1.4%
H
225.3
373.4
|
L
 1.4%
H
225.3
373.4
|
| Revvity |
|
13,037.8
|
116.8
|
L
 -0.6%
H
115.7
117.7
|
L
 1.9%
H
112.7
118.3
|
L
 5.1%
H
102.4
118.3
|
L
 21.2%
H
93.0
118.3
|
L
 30.6%
H
81.2
118.3
|
L
 -0.8%
H
79.5
129.5
|
L
 -36.2%
H
79.5
203.2
|
L
 114.7%
H
45.4
203.2
|
| Aethlon Medical Inc |
|
1.5
|
2.8
|
L
 -3.4%
H
2.8
3.1
|
L
 -10.2%
H
2.8
3.2
|
L
 316.2%
H
0.5
3.8
|
L
 32.2%
H
0.5
3.8
|
L
 -75.8%
H
0.5
27.4
|
L
 -98.9%
H
0.5
272.7
|
L
 -99.9%
H
0.5
4791.9
|
L
 -100.0%
H
0.5
83268
|
| Airsculpt Tech Inc |
|
247.3
|
3.4
|
L
 1.5%
H
3.3
3.5
|
L
 -31.5%
H
2.5
3.5
|
L
 -18.3%
H
2.5
5.2
|
L
 -27.6%
H
2.5
5.8
|
L
 -45.0%
H
1.5
12
|
L
 -55.6%
H
1.5
12
|
L
H
1.5
18.5
|
L
H
1.5
18.5
|
| Align Tech |
|
12,880.2
|
181.3
|
L
 2.9%
H
176.7
182.2
|
L
 4.4%
H
169.5
182.2
|
L
 1.6%
H
164.7
188.0
|
L
 12.9%
H
151.6
191.0
|
L
 26.9%
H
122
200.4
|
L
 -49.7%
H
122
375.7
|
L
 -73.8%
H
122
737.5
|
L
 89.6%
H
83.3
737.5
|
| Angiodynamic Inc |
|
655.1
|
15.9
|
L
 1.2%
H
15.5
15.9
|
L
 1.0%
H
15.2
16.1
|
L
 21.9%
H
12.8
16.1
|
L
 43.7%
H
10.7
16.1
|
L
 81.6%
H
8.7
16.1
|
L
 88.0%
H
5.3
16.1
|
L
 -41.6%
H
5.3
32
|
L
 0.8%
H
5.3
32
|
| Anika Therapeutics Inc |
|
287.7
|
21.5
|
L
 1.6%
H
21.0
22.0
|
L
 0.4%
H
20.4
22.9
|
L
 38.5%
H
14.6
22.9
|
L
 40.2%
H
13.8
22.9
|
L
 148.8%
H
8.2
22.9
|
L
 11.9%
H
7.9
29.1
|
L
 -48.6%
H
7.9
45.8
|
L
 -55.9%
H
7.9
75.7
|
| Anzu Special Acq Corp I (Class A) |
|
-
|
0.8
|
L
 6.7%
H
0.7
0.8
|
L
 19.4%
H
0.7
0.8
|
L
 5.3%
H
0.6
0.8
|
L
 21.2%
H
0.6
0.9
|
L
 -45.2%
H
0.4
1.9
|
L
 -92.2%
H
0.4
11.7
|
L
 -91.7%
H
0.4
11.7
|
L
H
0.4
11.7
|
| Apyx Medical Corp |
|
127.6
|
3.0
|
L
 -0.3%
H
2.9
3.1
|
L
 -25.2%
H
2.9
3.9
|
L
 -28.2%
H
2.9
4.5
|
L
 -30.5%
H
2.9
5.1
|
L
 42.9%
H
1.7
5.1
|
L
 -37.1%
H
0.8
5.1
|
L
 -72.2%
H
0.8
17.5
|
L
H
0.8
17.5
|
| Accuray Inc |
|
33.4
|
0.3
|
L
H
0.3
0.3
|
L
H
0.3
0.3
|
L
 7.7%
H
0.2
0.3
|
L
H
0.2
0.4
|
L
 -80.8%
H
0.2
2.1
|
L
 -91.1%
H
0.2
3.2
|
L
 -92.3%
H
0.2
5.9
|
L
 -94.9%
H
0.2
6.4
|
| Alphatec Holdings Inc |
|
1,512.1
|
9.8
|
L
 0.4%
H
9.7
9.9
|
L
 5.2%
H
9.1
9.9
|
L
 9.1%
H
8.0
10.4
|
L
 29.3%
H
7.3
10.4
|
L
 -37.1%
H
6.8
23.3
|
L
 -34.4%
H
4.9
23.3
|
L
 -24.2%
H
4.9
23.3
|
L
 126.6%
H
1.2
23.3
|
| Atricure Inc |
|
2,253.4
|
44.3
|
L
 1.9%
H
43.2
44.5
|
L
 7.0%
H
41.0
44.5
|
L
 29.1%
H
31.9
44.5
|
L
 57.4%
H
25.4
44.5
|
L
 25.1%
H
25.4
44.5
|
L
 -14.3%
H
18.9
52.3
|
L
 -39.5%
H
18.9
89.2
|
L
 186.2%
H
14.4
89.2
|
| Axogen Inc |
|
2,619.8
|
48.7
|
L
 1.4%
H
47.3
48.8
|
L
 5.0%
H
46.0
49.9
|
L
 25.7%
H
38.3
49.9
|
L
 19%
H
38.1
49.9
|
L
 227.1%
H
13.6
49.9
|
L
 696.2%
H
3.5
49.9
|
L
 206.7%
H
3.5
49.9
|
L
 437.3%
H
3.5
56.9
|
| Bone Biologics Corp |
|
1.2
|
0.7
|
L
 -1.5%
H
0.6
0.7
|
L
 -29.0%
H
0.6
1.0
|
L
 -47.6%
H
0.6
1.3
|
L
 -48.0%
H
0.6
1.5
|
L
 -71.9%
H
0.6
4.1
|
L
 -98.9%
H
0.6
63.8
|
L
 -100.0%
H
0.6
10255.5
|
L
 -100.0%
H
0.6
169920
|
| BioAffinity Tech Inc |
|
3.2
|
0.4
|
L
 5.3%
H
0.4
0.4
|
L
 -21.6%
H
0.3
0.5
|
L
 -43.7%
H
0.3
0.7
|
L
 -79.9%
H
0.3
2.2
|
L
 -94.8%
H
0.3
13.5
|
L
 -99.3%
H
0.3
108.6
|
L
H
0.3
466.5
|
L
H
0.3
466.5
|
| Bluejay Diagnostics Inc |
|
1.1
|
1.1
|
L
 -0.9%
H
1.0
1.1
|
L
 -1.9%
H
1.0
1.1
|
L
 -16%
H
0.8
1.7
|
L
 -39.7%
H
0.8
7
|
L
 -80.0%
H
0.8
16.7
|
L
 -100.0%
H
0.8
13904
|
L
H
0.8
200000
|
L
H
0.8
200000
|
| Biolife Soln Inc |
|
1,715.2
|
35.1
|
L
 -0.5%
H
34.8
35.2
|
L
 1.2%
H
33.8
35.4
|
L
 22.4%
H
28.5
35.4
|
L
 66.5%
H
20.3
35.4
|
L
 38.5%
H
17.9
35.4
|
L
 178.3%
H
8.9
35.4
|
L
 -22.6%
H
8.9
60.7
|
L
 1586.1%
H
1.4
60.7
|
| Biomerica Inc |
|
4.9
|
1.6
|
L
 -2.5%
H
1.5
1.6
|
L
 -1.9%
H
1.5
1.7
|
L
 -3.1%
H
1.5
1.7
|
L
 -34.4%
H
1.5
2.5
|
L
 -55.0%
H
1.5
3.6
|
L
 29.5%
H
0.2
4.9
|
L
 -61.1%
H
0.2
7.4
|
L
 -47.3%
H
0.2
23.4
|
| Bruker Corp |
|
8,791.1
|
57.7
|
L
 -0.4%
H
56.7
58.2
|
L
 8.0%
H
53.1
59.7
|
L
 -3.6%
H
48.6
65.3
|
L
 30.7%
H
41.6
65.3
|
L
 71.5%
H
28.5
65.3
|
L
 -15.9%
H
28.5
94.9
|
L
 -30.4%
H
28.5
94.9
|
L
 158.6%
H
19.6
94.9
|
| BioRestorative Therapies Inc |
|
5.9
|
0.2
|
L
 4.6%
H
0.2
0.2
|
L
 15%
H
0.2
0.2
|
L
 -30.3%
H
0.2
0.4
|
L
 21.1%
H
0.2
0.7
|
L
 -84.7%
H
0.2
1.9
|
L
 -91.7%
H
0.2
3.7
|
L
 -98.5%
H
0.2
26.8
|
L
 -100.0%
H
0.2
20040
|
| Bioventus Inc (Class A) |
|
1,199.2
|
14.3
|
L
 2.7%
H
13.7
14.4
|
L
 1.0%
H
13.4
14.4
|
L
 23.4%
H
11.4
15.9
|
L
 34.4%
H
7.8
15.9
|
L
 94.3%
H
6.3
15.9
|
L
 200.8%
H
2.8
15.9
|
L
 -5.4%
H
0.8
17.5
|
L
H
0.8
19.9
|
| Brainsway Ltd (ADR) |
|
654.9
|
16.3
|
L
 -0.9%
H
15.9
16.7
|
L
 5.3%
H
14.8
17.4
|
L
 12.9%
H
14.1
17.4
|
L
H
13.8
17.4
|
L
 408.4%
H
3.1
17.4
|
L
 2076%
H
0.7
17.4
|
L
 700%
H
0.3
17.4
|
L
H
0.3
17.4
|
| Cardio Diagnostics Holdings Inc |
|
6.0
|
2.0
|
L
 1.5%
H
2.0
2.1
|
L
 14.0%
H
1.6
2.3
|
L
 13.3%
H
1.4
2.3
|
L
 21.4%
H
1.3
2.6
|
L
 -49.3%
H
1.0
7.9
|
L
 -92.6%
H
1.0
106.8
|
L
H
1.0
307.5
|
L
H
1.0
307.5
|
| Caredx Inc |
|
2,344.6
|
45.3
|
L
 -4.4%
H
45.3
47.3
|
L
 -2.9%
H
45.3
48.3
|
L
 56.7%
H
28.9
49.8
|
L
 121.2%
H
19.6
49.8
|
L
 283.4%
H
11.3
49.8
|
L
 385.2%
H
4.8
49.8
|
L
 -35.1%
H
4.8
81.5
|
L
 850.1%
H
0.8
99.8
|
| Celcuity Inc |
|
4,501.7
|
92
|
L
 6.2%
H
83.0
95.6
|
L
 -0.8%
H
83.0
95.6
|
L
 -17.2%
H
78.6
98
|
L
 -31.7%
H
78.6
142.8
|
L
 77.3%
H
44.4
151.0
|
L
 839.7%
H
7.6
151.0
|
L
 331.5%
H
4.8
151.0
|
L
H
4.0
151.0
|
| Creative Medical Tech Holdings Inc |
|
8.0
|
1.2
|
L
 -1.6%
H
1.2
1.3
|
L
 -14.1%
H
1.1
1.5
|
L
 45.2%
H
0.6
1.9
|
L
 -45.5%
H
0.6
4.7
|
L
 -60.3%
H
0.6
6.3
|
L
 -76.6%
H
0.6
10.3
|
L
 -99.2%
H
0.6
171.5
|
L
 -100.0%
H
0.6
525000
|
| Cerus Corp |
|
600.5
|
3.0
|
L
 4.9%
H
2.8
3
|
L
 26.8%
H
2.3
3
|
L
 -2.9%
H
2.1
3.3
|
L
 18.7%
H
2.1
3.5
|
L
 134.7%
H
1.2
3.5
|
L
 54.4%
H
1.1
3.5
|
L
 -50.4%
H
1.1
8.1
|
L
 -57.4%
H
1.1
8.9
|
| Check-Cap Ltd |
|
11.8
|
8.7
|
L
 -1.3%
H
8.6
9.2
|
L
 -11.7%
H
1.2
10.2
|
L
 10.2%
H
1.2
10.5
|
L
 -30.4%
H
1.2
13.7
|
L
 84.0%
H
1.2
27.4
|
L
 -59.8%
H
1.2
32.4
|
L
 -94.2%
H
1.2
183.4
|
L
 -99.7%
H
1.2
4956
|
| CollPlant biotech Ltd - Ordinary Shares New |
|
6.2
|
0.3
|
L
 3.1%
H
0.3
0.3
|
L
 -2.9%
H
0.3
0.4
|
L
 -8.3%
H
0.3
0.4
|
L
 -21.4%
H
0.3
0.5
|
L
 -87.4%
H
0.3
3.2
|
L
 -95.1%
H
0.3
7.9
|
L
 -98.2%
H
0.3
23
|
L
 -98.2%
H
0.3
24.3
|
| ClearPoint Neuro Inc |
|
467.9
|
15.3
|
L
 -0.5%
H
15.2
15.6
|
L
 8.0%
H
14.3
15.6
|
L
 -3.9%
H
12.3
16.2
|
L
 20.1%
H
10.9
19.6
|
L
 31.3%
H
8.3
30.1
|
L
 147.8%
H
4.1
30.1
|
L
 -13.3%
H
4.1
30.1
|
L
 80.5%
H
1.3
31.3
|
| Cardiff Oncology Inc |
|
74.7
|
1.0
|
L
 -2.0%
H
1.0
1.0
|
L
 -3.0%
H
0.9
1.1
|
L
 -26.7%
H
0.8
1.1
|
L
 -44.5%
H
0.8
2
|
L
 -60.7%
H
0.8
3.3
|
L
 -52%
H
0.8
6.4
|
L
 -83.3%
H
0.8
8.6
|
L
 -99.8%
H
0.7
430.6
|
| Castle Biosciences Inc |
|
904.9
|
29.6
|
L
 -3.0%
H
29.6
31.1
|
L
 -7.5%
H
29.6
33.1
|
L
 28.1%
H
22.9
33.1
|
L
 56.9%
H
18.5
33.1
|
L
 49.5%
H
17.7
44.3
|
L
 57.6%
H
12.1
44.3
|
L
 -54.0%
H
9.3
78.6
|
L
H
9.3
107.7
|
| Cytek BioSciences Inc |
|
609.6
|
4.7
|
L
 -4.1%
H
4.7
4.9
|
L
 11.7%
H
4.2
4.9
|
L
 1.5%
H
4.0
4.9
|
L
 39.6%
H
3.3
4.9
|
L
 15.0%
H
3.3
6.2
|
L
 -47.4%
H
2.4
9.9
|
L
 -77.3%
H
2.4
28.7
|
L
H
2.4
28.7
|
| Cytosorbents Corp |
|
25.1
|
0.4
|
L
 11.1%
H
0.4
0.4
|
L
 11.1%
H
0.4
0.4
|
L
 2.6%
H
0.4
0.4
|
L
 -25.9%
H
0.4
0.6
|
L
 -64.9%
H
0.4
1.2
|
L
 -86.2%
H
0.4
3.0
|
L
 -94.9%
H
0.4
9.8
|
L
 -91.5%
H
0.4
15.0
|
| Citius Pharma Inc |
|
20.9
|
0.8
|
L
 4.1%
H
0.7
0.8
|
L
 11.8%
H
0.7
0.8
|
L
 43.4%
H
0.5
0.8
|
L
 5.6%
H
0.5
0.8
|
L
 -42.0%
H
0.5
2.2
|
L
 -96.7%
H
0.1
26.8
|
L
 -98.3%
H
0.1
58.8
|
L
 -99.7%
H
0.1
371.3
|
| CVRx Inc |
|
82.1
|
3.1
|
L
 4.8%
H
2.9
3.2
|
L
 28.9%
H
2.2
3.2
|
L
 -40.3%
H
2.2
6
|
L
 -46.3%
H
2.2
6.4
|
L
 -57.5%
H
2.2
11.3
|
L
 -82.8%
H
2.2
33.1
|
L
 -83.7%
H
2.2
33.1
|
L
H
2.2
33.1
|
| Delcath Systems Inc |
|
580.5
|
16.7
|
L
 -3.6%
H
16.7
17.4
|
L
 10.7%
H
15
17.4
|
L
 27.3%
H
11.5
17.4
|
L
 46.0%
H
10.2
17.4
|
L
 59.8%
H
8.1
17.4
|
L
 436.2%
H
2.3
18.2
|
L
 82.6%
H
2.3
18.2
|
L
 -100.0%
H
2.3
527975000
|
| DarioHealth Corp |
|
74.3
|
7.6
|
L
 3.4%
H
7.2
7.9
|
L
 3.8%
H
6.8
8.0
|
L
 16.1%
H
6.1
8.2
|
L
 -9.6%
H
5.8
8.8
|
L
 -13.1%
H
5.8
17.7
|
L
 -88.0%
H
5.8
69.8
|
L
 -96.8%
H
5.8
387.8
|
L
 -99.5%
H
5.8
1880
|
| Alpha Tau Medical Ltd |
|
1,317.8
|
14.3
|
L
 -1.7%
H
14.1
14.5
|
L
 8.5%
H
13.1
14.8
|
L
 15.5%
H
11.0
14.8
|
L
 36.9%
H
8.8
14.8
|
L
 345.3%
H
3
14.8
|
L
 269.2%
H
1.8
14.8
|
L
H
1.8
20.7
|
L
H
1.8
20.7
|
| DexCom |
|
33,868.1
|
89.8
|
L
 -1.9%
H
89.4
92.0
|
L
 5.9%
H
84.5
92.0
|
L
 21.1%
H
69.8
92.0
|
L
 55.2%
H
59.5
92.0
|
L
 12.2%
H
54.1
92.0
|
L
 -22.5%
H
54.1
142
|
L
 -26.9%
H
54.1
164.9
|
L
 296.6%
H
10.7
164.9
|
| ElectroCore Inc |
|
89.9
|
10.0
|
L
 0.3%
H
9.7
10.4
|
L
 23.2%
H
7.7
10.4
|
L
 62.1%
H
5.6
10.4
|
L
 55.1%
H
5.6
10.5
|
L
 90.3%
H
4.4
10.5
|
L
 102.6%
H
4.2
19.5
|
L
 -33.2%
H
2.9
19.5
|
L
H
2.9
303.8
|
| ChronoScale Corp |
|
3,039.3
|
20.9
|
L
 1.5%
H
20.6
21.7
|
L
H
18.9
22.5
|
L
 -9.0%
H
17.1
30
|
L
 16.8%
H
13.5
30
|
L
 556.1%
H
3.0
30
|
L
 -91.8%
H
2.7
704.0
|
L
 -98.1%
H
2.7
1164.2
|
L
 -99.8%
H
2.7
21532.5
|
| Embecta Corp |
|
289.0
|
5.1
|
L
 -0.2%
H
5.0
5.2
|
L
 15.4%
H
4.2
5.2
|
L
 64.5%
H
3.1
5.2
|
L
 62.4%
H
2.8
5.2
|
L
 -63.2%
H
2.8
15.6
|
L
 -75.2%
H
2.8
21.5
|
L
H
2.8
63
|
L
H
2.8
63
|
| Establishment Labs Holdings Inc |
|
2,368.4
|
79.5
|
L
 5.1%
H
75.8
81.3
|
L
 2.7%
H
73.8
81.3
|
L
 -8.2%
H
73.8
97.6
|
L
 13.9%
H
64.2
97.6
|
L
 109.4%
H
36.5
97.6
|
L
 39.8%
H
17
97.6
|
L
 16.6%
H
17
97.6
|
L
H
7.6
97.6
|
| EDAP TMS S.A. (ADR) |
|
178.4
|
4.8
|
L
 2.8%
H
4.5
4.8
|
L
 -23.5%
H
4.5
6.3
|
L
 -12.2%
H
4.5
6.4
|
L
 15.3%
H
4.0
6.4
|
L
 252.6%
H
1.3
6.4
|
L
 -42.4%
H
1.2
8.6
|
L
 -15%
H
1.2
12.7
|
L
 56.6%
H
1.2
12.7
|
| GlucoTrack Inc |
|
2.9
|
0.4
|
L
H
0.4
0.4
|
L
 -14.0%
H
0.4
0.4
|
L
 -30.2%
H
0.3
0.9
|
L
 -44.8%
H
0.3
0.9
|
L
 -93.5%
H
0.3
14.1
|
L
 -100.0%
H
0.3
5940
|
L
 -100.0%
H
0.3
39000
|
L
 -100.0%
H
0.3
468000
|
| GE HealthCare Tech |
|
33,284.8
|
73.7
|
L
 -0.1%
H
73.4
74.0
|
L
 2.7%
H
71.0
74.0
|
L
 19.5%
H
60.2
74.0
|
L
 17.6%
H
60.0
74.0
|
L
 0.0%
H
58.8
89.8
|
L
 2.6%
H
57.7
94.8
|
L
H
53
94.8
|
L
H
53
94.8
|
| Guardant Health Inc |
|
21,097.0
|
157.2
|
L
 -1.5%
H
156.2
159.7
|
L
 -6.7%
H
156.2
171.9
|
L
 -1.8%
H
140.9
176.6
|
L
 59.4%
H
92.5
176.6
|
L
 160.5%
H
53.4
176.6
|
L
 339.0%
H
15.8
176.6
|
L
 55.2%
H
15.8
176.6
|
L
H
15.8
181.1
|
| Harvard Bioscience Inc |
|
30.3
|
6.7
|
L
 -0.2%
H
6.5
6.7
|
L
 2.9%
H
6.1
6.7
|
L
 12.3%
H
5.9
6.7
|
L
 20.7%
H
4.9
6.7
|
L
 36.2%
H
3.8
9.4
|
L
 -83.4%
H
2.8
55.6
|
L
 -92.1%
H
2.8
84.8
|
L
 -74.9%
H
2.8
87.5
|
| Cue Health Inc |
|
4,384.6
|
27.6
|
L
 0.1%
H
27.3
27.6
|
L
 1.5%
H
27.3
28.0
|
L
H
24.9
28.0
|
L
H
24.9
28.0
|
L
H
24.9
28.0
|
L
 7152.6%
H
0
28.0
|
L
H
0
28.0
|
L
H
0
28.0
|
| Heart Test Laboratories Inc |
|
8.0
|
2.1
|
L
H
2.0
2.2
|
L
 2.0%
H
1.9
2.2
|
L
 -21.4%
H
1.9
2.9
|
L
 7.9%
H
1.6
3.8
|
L
 -41.1%
H
1.6
3.9
|
L
 -97.6%
H
1.6
86
|
L
H
1.6
600
|
L
H
1.6
600
|
| Helius Medical Tech Inc (Class A) |
|
99.3
|
1.7
|
L
 -5.6%
H
1.7
1.8
|
L
 0.6%
H
1.7
1.8
|
L
 -2.9%
H
1.6
1.8
|
L
 -28.9%
H
1.2
2.4
|
L
 -71.8%
H
1.2
25.5
|
L
 -100.0%
H
1.2
10072.5
|
L
 -100.0%
H
1.2
588000
|
L
 -100.0%
H
1.2
27168750
|
| Hyperfine Inc (Class A) |
|
94.4
|
0.9
|
L
H
0.9
0.9
|
L
 -7.3%
H
0.9
1.0
|
L
 -14.4%
H
0.9
1.1
|
L
 -44.4%
H
0.9
1.7
|
L
 -38.6%
H
0.9
2.2
|
L
 -62.1%
H
0.5
2.8
|
L
 -91.0%
H
0.5
16.6
|
L
H
0.5
16.6
|
| Integra Lifesciences Holdings Corp |
|
1,426.3
|
18.3
|
L
 0.6%
H
17.7
18.5
|
L
 6.3%
H
17
18.6
|
L
 -0.3%
H
16.0
20.5
|
L
 26.5%
H
13.8
20.5
|
L
 34.7%
H
8.7
20.5
|
L
 -57.9%
H
8.7
45.4
|
L
 -74.2%
H
8.7
76.7
|
L
 -56.2%
H
8.7
77.4
|
| Icecure Medical Ltd |
|
10.3
|
3.0
|
L
 0.7%
H
3.0
3.2
|
L
 -2.0%
H
2.9
3.6
|
L
 -16.1%
H
2.7
3.7
|
L
 -58.2%
H
2.1
9.5
|
L
 -88.0%
H
2.1
42
|
L
 -89.5%
H
2.1
49.8
|
L
 -99.1%
H
2.1
372
|
L
 -91.3%
H
2.1
480
|
| SeaStar Medical Holding Corp |
|
12.7
|
3.2
|
L
 0.3%
H
3.1
3.3
|
L
 -3.1%
H
3.0
3.9
|
L
 -33.8%
H
3.0
4.8
|
L
 -24.3%
H
2.6
5.4
|
L
 -96.4%
H
2.1
125
|
L
 -99.6%
H
2.1
4292.3
|
L
 -100.0%
H
2.1
55000
|
L
H
2.1
55000
|
| ICU Medical Inc |
|
4,575.8
|
183.0
|
L
 -0.1%
H
181.3
184.3
|
L
 -0.9%
H
177.0
186.2
|
L
 19.2%
H
152.7
192.9
|
L
 48.8%
H
118.1
192.9
|
L
 63.5%
H
112.5
192.9
|
L
 28.2%
H
78.4
196.3
|
L
 -2.6%
H
78.4
282
|
L
 46.8%
H
78.4
321.7
|
| Idexx Laboratories |
|
43,405.2
|
551.0
|
L
 -2.8%
H
549.2
569.1
|
L
 -6.1%
H
549.2
602
|
L
 1.9%
H
534.4
624.2
|
L
 3.4%
H
518.6
624.2
|
L
 -15.8%
H
518.6
770.0
|
L
 8.5%
H
356.3
770.0
|
L
 -18.0%
H
317.1
770.0
|
L
 397.3%
H
102.5
770.0
|
| QTREX Quantum |
|
54.6
|
1.0
|
L
 -2%
H
0.9
1
|
L
 -6.7%
H
0.9
1.1
|
L
 -34.7%
H
0.8
1.5
|
L
 145%
H
0.3
3.9
|
L
 -22.2%
H
0.3
3.9
|
L
 -31.5%
H
0.3
3.9
|
L
 -75%
H
0.3
9.6
|
L
H
0.3
9.6
|
| Illumina Inc |
|
28,824.4
|
190.9
|
L
 -0.9%
H
188
192.8
|
L
 1.6%
H
186.6
194.5
|
L
 -0.2%
H
178.9
207
|
L
 33.3%
H
138.1
207
|
L
 90.7%
H
88
207
|
L
 9.0%
H
68.7
207
|
L
 -63.1%
H
68.7
526
|
L
 14.3%
H
68.7
555.8
|
| Intercure Ltd |
|
58.6
|
1.0
|
L
 6.5%
H
0.9
1.0
|
L
 1.0%
H
0.9
1
|
L
H
0.9
1
|
L
 20.7%
H
0.8
1.2
|
L
 -40.4%
H
0.7
1.7
|
L
 -36.1%
H
0.7
3.7
|
L
 -84.2%
H
0.7
8.8
|
L
H
0.7
19.4
|
| Inogen Inc |
|
152.6
|
5.8
|
L
 -1.0%
H
5.7
5.8
|
L
 -5.0%
H
5.7
6.3
|
L
 -9.2%
H
5.6
6.9
|
L
 -15.4%
H
5.6
7.1
|
L
 -25.0%
H
5.3
9.1
|
L
 -6.5%
H
4.1
13.3
|
L
 -90.8%
H
4.1
63.6
|
L
 -89.9%
H
4.1
287.8
|
| Inmode Ltd |
|
871.8
|
15.2
|
L
 -0.3%
H
15.1
15.3
|
L
 -1.1%
H
15.0
15.4
|
L
 1.5%
H
14.9
15.7
|
L
 7.8%
H
13.2
15.7
|
L
 6.1%
H
12.7
16.7
|
L
 -63.1%
H
12.7
40.8
|
L
 -72.1%
H
12.7
99.3
|
L
H
6.5
99.3
|
| NAYA Biosciences |
|
1.7
|
1.0
|
L
H
1.0
1.0
|
L
 -8.5%
H
1.0
1.1
|
L
 -14.2%
H
0.9
1.2
|
L
 -37.8%
H
0.9
3.1
|
L
 -98.6%
H
0.9
84.4
|
L
 -100.0%
H
0.9
5040
|
L
 -100.0%
H
0.9
123264
|
L
 -100.0%
H
0.9
709632
|
| IRIDEX Corp |
|
15.0
|
0.9
|
L
 4.9%
H
0.8
0.9
|
L
 3.6%
H
0.8
0.9
|
L
 -19.6%
H
0.8
1.1
|
L
 -14.9%
H
0.8
1.2
|
L
 -23.2%
H
0.8
1.7
|
L
 -42.7%
H
0.8
3.7
|
L
 -89.2%
H
0.8
9.5
|
L
 -93.9%
H
0.8
16.4
|
| Iradimed Corp |
|
1,111.8
|
87.0
|
L
 0.0%
H
85
87.2
|
L
 -6%
H
85
93.3
|
L
 -5.2%
H
85
98.6
|
L
 0.3%
H
85
103.0
|
L
 24.0%
H
67.8
107.9
|
L
 78.7%
H
36.1
107.9
|
L
 156.3%
H
26
107.9
|
L
 401.2%
H
7.9
107.9
|
| iRhythm Tech Inc |
|
4,167.8
|
126.4
|
L
 2.7%
H
120.5
128
|
L
 -1.1%
H
120
128
|
L
 12.3%
H
105.3
136.7
|
L
 10.8%
H
100.9
136.7
|
L
 -22%
H
100.9
212
|
L
 8.7%
H
55.9
212
|
L
 177.3%
H
41.7
212
|
L
H
22.2
286.2
|
| Intuitive Surgical |
|
141,344.3
|
394.5
|
L
 -1.7%
H
394.1
402.5
|
L
 4.1%
H
378
405.0
|
L
 4.0%
H
328.6
405.5
|
L
 -7.8%
H
328.6
449.8
|
L
 -17.3%
H
328.6
603.9
|
L
 29.3%
H
254.9
616
|
L
 18.0%
H
180.1
616
|
L
 413.9%
H
67.9
616
|
| Kewaunee Scientific Corp |
|
104.7
|
36.5
|
L
 -0.1%
H
36.5
36.5
|
L
 -1.6%
H
36
37.3
|
L
 0.5%
H
35.0
38.7
|
L
 -5.6%
H
33.3
41.2
|
L
 -35.4%
H
33.3
60.9
|
L
 138.1%
H
15.1
71.3
|
L
 170.4%
H
12.1
71.3
|
L
 71.4%
H
7.0
71.3
|
| OrthoPediatrics corp |
|
647.5
|
24.8
|
L
 -0.8%
H
24.7
25.4
|
L
 8.9%
H
22.8
25.4
|
L
 28.8%
H
18.1
25.4
|
L
 38.6%
H
16.4
25.4
|
L
 29.6%
H
14.4
25.4
|
L
 -36.1%
H
14.4
39.1
|
L
 -60.9%
H
14.4
73.9
|
L
H
14
73.9
|
| KORU Medical Systems Inc |
|
157.0
|
3.4
|
L
 2.4%
H
3.3
3.5
|
L
 -4.2%
H
3.3
3.6
|
L
 -18.1%
H
3.2
4.4
|
L
 -14.6%
H
3.2
4.7
|
L
 -17.5%
H
3.2
6.6
|
L
 32.3%
H
1.9
6.6
|
L
 -0.9%
H
1.8
6.6
|
L
 690.7%
H
0.3
12.8
|
| Standard BioTools Inc |
|
278.7
|
0.7
|
L
 -5.3%
H
0.7
0.8
|
L
 -11.3%
H
0.7
0.8
|
L
 -15.5%
H
0.7
0.9
|
L
 -29%
H
0.7
1.3
|
L
 -41.8%
H
0.7
1.7
|
L
 -75.5%
H
0.7
3.2
|
L
 -89.4%
H
0.7
7.3
|
L
 -92.1%
H
0.7
14.9
|
| LivaNova PLC |
|
4,529.8
|
82.2
|
L
 0.0%
H
80.0
82.3
|
L
 7.9%
H
75.0
82.7
|
L
 3.9%
H
74.7
85.8
|
L
 14.7%
H
69.6
85.8
|
L
 51.9%
H
48.8
85.8
|
L
 47.5%
H
32.5
85.8
|
L
 6.9%
H
32.5
93.9
|
L
 30.9%
H
32.5
131.5
|
| Lemaitre Vascular Inc |
|
1,884.0
|
82.4
|
L
 0.6%
H
80.7
82.6
|
L
 1.1%
H
79.5
83.1
|
L
 -15.8%
H
78.7
106.3
|
L
 -17.2%
H
78.7
106.3
|
L
 -14.0%
H
78.7
118.0
|
L
 45.6%
H
44.3
118.0
|
L
 49.2%
H
38.3
118.0
|
L
 376.7%
H
16.8
118.0
|
| LENSAR Inc |
|
188.8
|
8.2
|
L
 -0.9%
H
8.1
8.7
|
L
 35.8%
H
5.9
8.7
|
L
 42.4%
H
5.0
8.7
|
L
 40.7%
H
5.0
8.7
|
L
 -34.4%
H
5.0
13.0
|
L
 131.0%
H
1.8
17.3
|
L
 -3.6%
H
1.8
17.3
|
L
H
1.8
17.3
|
| Lantheus Holdings Inc |
|
6,589.2
|
101.0
|
L
 0.0%
H
100.9
101.1
|
L
H
100.6
101.1
|
L
 -1.4%
H
98.8
109.5
|
L
 4.4%
H
91.7
111.9
|
L
 85.3%
H
49.7
111.9
|
L
 46.2%
H
47.3
126.9
|
L
 295.6%
H
22.2
126.9
|
L
 1465.1%
H
6.6
126.9
|
| Lucid Diagnostics Inc |
|
197.1
|
1.0
|
L
 1.0%
H
1.0
1
|
L
H
1.0
1.0
|
L
 -3%
H
0.9
1.2
|
L
 -4.9%
H
0.9
1.2
|
L
 -1.0%
H
0.9
1.6
|
L
 -34.5%
H
0.6
1.8
|
L
H
0.6
13.5
|
L
H
0.6
13.5
|
| Pulmonx Corp |
|
103.9
|
2.4
|
L
 12.0%
H
2.2
2.5
|
L
 18.6%
H
2.0
2.5
|
L
 63.5%
H
1.2
2.5
|
L
 80.6%
H
1.2
2.5
|
L
 60.3%
H
1.1
2.9
|
L
 -77.8%
H
1.1
14.8
|
L
 -93.4%
H
1.1
45.5
|
L
H
1.1
69.5
|
| 908 Devices Inc |
|
413.8
|
10.0
|
L
 -1.0%
H
10.0
10.4
|
L
 12.7%
H
8.6
10.5
|
L
 22.7%
H
6.9
10.5
|
L
 37.1%
H
6.5
10.5
|
L
 41.6%
H
5.0
10.5
|
L
 41.2%
H
1.8
12.5
|
L
 -69.0%
H
1.8
39.8
|
L
H
1.8
79.6
|
| Mimedx Grp Inc |
|
622.4
|
4.3
|
L
 1.7%
H
4.1
4.3
|
L
 -1.6%
H
4.1
4.4
|
L
 1.7%
H
3.8
4.5
|
L
 20.3%
H
3.5
4.5
|
L
 -40.3%
H
3.0
8.0
|
L
 -42.8%
H
3.0
10.1
|
L
 -64.5%
H
2.4
16.0
|
L
 -43.2%
H
1.0
18.3
|
| Mesa Laboratories Inc |
|
593.4
|
106.0
|
L
 -6.3%
H
105.2
115.4
|
L
 3.3%
H
93.0
115.5
|
L
 12.1%
H
93.0
115.5
|
L
 5.5%
H
81.3
115.5
|
L
 56.2%
H
58.8
115.5
|
L
 -24.4%
H
55.5
155.1
|
L
 -62.0%
H
55.5
333.4
|
L
 2.5%
H
55.5
333.4
|
| Merit Medical Systems Inc |
|
5,419.3
|
90.8
|
L
 0.3%
H
90.0
91.0
|
L
 1.9%
H
89.0
92.3
|
L
 27.8%
H
71.0
92.3
|
L
 45.1%
H
60.0
92.3
|
L
 6.5%
H
59.7
94.8
|
L
 32.9%
H
59.7
111.5
|
L
 37.5%
H
50.5
111.5
|
L
 286.0%
H
19.5
111.5
|
| Modular Medical Inc |
|
13.5
|
2.5
|
L
 33.2%
H
1.9
2.5
|
L
 13.2%
H
1.7
2.5
|
L
 -42.2%
H
1.7
4.9
|
L
 -28.0%
H
1.7
6
|
L
 -88.7%
H
1.7
30
|
L
 -92.1%
H
1.7
79.5
|
L
 -99.3%
H
1.7
450
|
L
 -89.8%
H
1.7
585.0
|
| MedTech Acq Corp (Class A) |
|
-
|
5.3
|
L
 -6.4%
H
5.2
5.6
|
L
 -6.1%
H
5.2
5.9
|
L
 30.5%
H
4.0
5.9
|
L
 109.1%
H
2.4
5.9
|
L
 35.8%
H
2.2
8.0
|
L
 2.5%
H
2.2
8.0
|
L
 -46.7%
H
2.2
12.8
|
L
H
2.2
12.8
|
| Myriad Genetics Inc |
|
289.8
|
3.0
|
L
 -4.4%
H
3.0
3.2
|
L
 -7.1%
H
3.0
3.3
|
L
 -49.8%
H
2.7
6.4
|
L
 -16.3%
H
2.7
6.4
|
L
 -48.6%
H
2.7
8.6
|
L
 -83.0%
H
2.7
29.3
|
L
 -90.8%
H
2.7
37.0
|
L
 -85.9%
H
2.7
50.4
|
| MDxHealth SA (ADR) |
|
-
|
0.8
|
L
 76.1%
H
0.6
1.1
|
L
 76.1%
H
0.4
1.1
|
L
 92.9%
H
0.4
1.1
|
L
 -17.4%
H
0.4
1.1
|
L
 -71.5%
H
0.4
5.3
|
L
 -78.0%
H
0.4
5.3
|
L
H
0.4
13.2
|
L
H
0.4
13.2
|
| ENvue Medical Inc |
|
4.1
|
0.4
|
L
 15.8%
H
0.4
0.5
|
L
 10%
H
0.3
0.5
|
L
 -4.4%
H
0.3
0.5
|
L
 -61.1%
H
0.3
1.1
|
L
 -93.5%
H
0.3
17.4
|
L
 -99.9%
H
0.3
465.3
|
L
 -100.0%
H
0.3
9218
|
L
 -100.0%
H
0.3
18700
|
| ENDRA Life Sciences Inc |
|
5.7
|
4.5
|
L
H
4.3
4.5
|
L
 -2.8%
H
4.3
4.6
|
L
 -19.3%
H
4.1
5.9
|
L
 -22.1%
H
3.6
6.7
|
L
 0.7%
H
3.0
9.9
|
L
 -92.9%
H
0.0
139.5
|
L
 -99.7%
H
0.0
2090
|
L
H
0.0
5880
|
| Neogen Corp |
|
2,540.4
|
11.7
|
L
 -2.0%
H
11.6
12.1
|
L
 1.6%
H
11.2
12.1
|
L
 20.5%
H
9.1
12.9
|
L
 38.2%
H
8.2
12.9
|
L
 111.8%
H
4.9
12.9
|
L
 -50.7%
H
3.9
24.1
|
L
 -72.5%
H
3.9
47.8
|
L
 -45.6%
H
3.9
48.9
|
| Nephros Inc |
|
50.2
|
4.6
|
L
 -1.5%
H
4.2
4.7
|
L
 9.7%
H
4
4.8
|
L
 30.1%
H
3.2
4.8
|
L
 38.3%
H
3.1
4.8
|
L
 15.5%
H
2.7
6.4
|
L
 202.0%
H
1.4
6.4
|
L
 -41.7%
H
0.9
9.1
|
L
 16.7%
H
0.9
11.7
|
| NeuroOne Medical Tech Corp |
|
17.0
|
1.9
|
L
 6.0%
H
1.8
2.0
|
L
 19.0%
H
1.5
2.0
|
L
 -20.2%
H
1.4
2.8
|
L
 -57.8%
H
1.4
4.6
|
L
 -61.0%
H
1.4
7.0
|
L
 -70.4%
H
1.4
12
|
L
 -92.7%
H
1.4
40.8
|
L
H
1.4
180
|
| Nano X Imaging Ltd |
|
74.3
|
1
|
L
 2.0%
H
1.0
1.0
|
L
 -5.7%
H
1.0
1.1
|
L
 -5.7%
H
0.9
1.2
|
L
 -43.5%
H
0.7
2.1
|
L
 -77.8%
H
0.7
4.7
|
L
 -89.7%
H
0.7
14.3
|
L
 -96.3%
H
0.7
28.6
|
L
H
0.7
94.8
|
| NeuroPace Inc |
|
507.0
|
14.8
|
L
 1.8%
H
14.3
14.8
|
L
 -0.4%
H
14.2
15.4
|
L
 -6.8%
H
12.7
16.8
|
L
 -6.5%
H
12.7
18.2
|
L
 63.6%
H
8.2
19.6
|
L
 230.4%
H
4.2
19.6
|
L
 -28.1%
H
1.2
24.7
|
L
H
1.2
27.4
|
| InspireMD Inc |
|
45.9
|
1.0
|
L
 16.7%
H
0.9
1.0
|
L
 32.4%
H
0.7
1.0
|
L
 36.1%
H
0.7
1.0
|
L
 -14.0%
H
0.6
1.2
|
L
 -60.8%
H
0.6
2.6
|
L
 -68.8%
H
0.6
3.9
|
L
 -74.2%
H
0.6
5.1
|
L
 -100.0%
H
0.6
117862.5
|
| Nortech Systems Inc |
|
34.6
|
12.1
|
L
 -5.0%
H
12.1
12.7
|
L
 -21.5%
H
12.1
15.6
|
L
 -14.0%
H
12.1
15.7
|
L
H
11.2
18.0
|
L
 38.4%
H
6.5
18.0
|
L
 22.3%
H
6.5
19.2
|
L
 8.7%
H
6.5
19.6
|
L
 203.5%
H
2.5
19.6
|
| Nutriband Inc |
|
40.1
|
3.3
|
L
 3.5%
H
3.2
3.3
|
L
 6.1%
H
3.1
3.3
|
L
 10.7%
H
2.8
3.3
|
L
 -8.1%
H
2.8
3.7
|
L
 -47.6%
H
2.8
8.6
|
L
 -4.1%
H
1.5
11.8
|
L
 -49.2%
H
1.5
12.9
|
L
H
0.9
43.5
|
| Nuwellis Inc |
|
0.1
|
1.3
|
L
 0.8%
H
1.3
1.4
|
L
 -12.1%
H
1.3
1.6
|
L
 -59.3%
H
1.3
6.4
|
L
 28.4%
H
0.1
6.4
|
L
 -76.8%
H
0.1
6.7
|
L
 -100.0%
H
0.1
3895.5
|
L
 -100.0%
H
0.1
702660
|
L
 -100.0%
H
0.1
10000000000
|
| NovoCure Ltd |
|
1,973.8
|
17.0
|
L
 -2.5%
H
16.8
17.2
|
L
 3.4%
H
16.3
17.8
|
L
 9%
H
14.8
21.5
|
L
 -6.1%
H
13.4
21.5
|
L
 46.3%
H
9.8
21.5
|
L
 -45.3%
H
9.8
34.1
|
L
 -87.8%
H
9.8
143.7
|
L
 114.6%
H
6.0
232.8
|
| enVVeno Medical Corp |
|
7.5
|
11.0
|
L
 1.2%
H
10.7
11.0
|
L
 3.6%
H
10.2
11.3
|
L
 0.8%
H
9.8
11.6
|
L
 6.7%
H
9.0
12.3
|
L
 -93.0%
H
8.7
178.2
|
L
 -93.6%
H
8.7
244.0
|
L
 -95.4%
H
8.7
398.3
|
L
H
8.7
4935
|
| Nexalin Tech Inc |
|
7.7
|
0.4
|
L
H
0.3
0.4
|
L
H
0.3
0.4
|
L
 -14.6%
H
0.3
0.5
|
L
 2.9%
H
0.3
0.6
|
L
 -56.3%
H
0.3
2
|
L
 -47.0%
H
0.3
4.5
|
L
H
0.3
4.5
|
L
H
0.3
4.5
|
| Nyxoah SA |
|
162.1
|
1.6
|
L
 2.5%
H
1.6
1.7
|
L
 10.2%
H
1.5
1.7
|
L
 2.5%
H
1.3
1.7
|
L
 -44.5%
H
1.3
3.2
|
L
 -76.2%
H
1.3
6.9
|
L
 -79.7%
H
1.3
20
|
L
 -94.7%
H
1.3
34.2
|
L
H
1.3
37
|
| Orchestra BioMed Holdings Inc |
|
265.1
|
4.4
|
L
 -0.9%
H
4.3
4.5
|
L
 4.0%
H
4.2
4.7
|
L
 19.5%
H
3.6
4.7
|
L
 7.3%
H
3.6
4.8
|
L
 65.8%
H
2.2
5.4
|
L
 -24.9%
H
2.2
11.7
|
L
 -55.4%
H
2.2
23.4
|
L
H
2.2
23.4
|
| Orthofix Medical Inc |
|
421.2
|
10.3
|
L
 1.6%
H
10.1
10.4
|
L
 0.6%
H
10.0
10.7
|
L
 -5.6%
H
10.0
12.6
|
L
 -15.9%
H
8.9
12.6
|
L
 -26.3%
H
8.9
17.0
|
L
 -45%
H
8.9
21.6
|
L
 -74.1%
H
8.9
43.3
|
L
 -76.2%
H
8.9
74.4
|
| Outset Medical Inc |
|
84.8
|
4.5
|
L
 6.1%
H
4.1
4.7
|
L
 -8.0%
H
4.1
5.3
|
L
 -0.7%
H
4.0
5.3
|
L
 18.4%
H
3.6
5.5
|
L
 -65.0%
H
3
16.2
|
L
 -98.1%
H
0.5
242.0
|
L
 -99.2%
H
0.5
905.0
|
L
H
0.5
1004.4
|
| Organogenesis Holdings Inc (Class A) |
|
230.3
|
1.8
|
L
 1.7%
H
1.7
1.8
|
L
 -3.8%
H
1.7
2.0
|
L
 -23.5%
H
1.5
2.7
|
L
 -30.9%
H
1.5
2.7
|
L
 -61.9%
H
1.5
7.1
|
L
 -33.7%
H
1.5
7.1
|
L
 -88.1%
H
1.5
17.5
|
L
H
1.5
310.9
|
| Orasure Tech Inc |
|
264.8
|
3.8
|
L
 -4.5%
H
3.8
4.0
|
L
 -5.2%
H
3.7
4.1
|
L
 -9.9%
H
3.7
4.3
|
L
 30.2%
H
3.0
4.6
|
L
 38.6%
H
2.1
4.6
|
L
 -39.6%
H
2.1
8.5
|
L
 -64.7%
H
2.1
13.6
|
L
 -44.9%
H
2.1
23.0
|
| Pacific Biosciences of California Inc |
|
357.5
|
1.2
|
L
H
1.1
1.2
|
L
 -2.5%
H
1.1
1.2
|
L
 -23.3%
H
1.1
1.6
|
L
 -5.0%
H
1.1
1.8
|
L
 -6.5%
H
1.1
2.7
|
L
 -90.0%
H
0.9
12.0
|
L
 -96.1%
H
0.9
32.6
|
L
 -86.1%
H
0.9
53.7
|
| PAVmed Inc |
|
37.2
|
5.2
|
L
 9.7%
H
4.3
5.3
|
L
 9.7%
H
4.2
5.3
|
L
 -8.3%
H
4.2
6.7
|
L
 -19.4%
H
3.9
6.7
|
L
 -62.0%
H
3.9
28.4
|
L
 -96.5%
H
3.9
270
|
L
 -99.8%
H
3.9
4365
|
L
 -99.9%
H
3.9
6520.5
|
| Pro-Dex Inc (co) |
|
214.0
|
67.0
|
L
 -1.3%
H
66.3
68.6
|
L
 2.2%
H
62.1
68.8
|
L
 15.0%
H
53
68.8
|
L
 14.3%
H
53
69.0
|
L
 64.6%
H
23.5
69.0
|
L
 306.2%
H
14.5
70.3
|
L
 123.4%
H
12.4
70.3
|
L
 1299.2%
H
3.8
70.3
|
| Pulse Biosciences Inc |
|
3,176.7
|
44.5
|
L
 -0.9%
H
43.8
45.5
|
L
 5.0%
H
40.7
47.0
|
L
 74.9%
H
24.9
47.0
|
L
 64.4%
H
23.6
47.0
|
L
 157.3%
H
12.6
47.0
|
L
 476.2%
H
3.8
47.0
|
L
 98.6%
H
1.2
47.0
|
L
 876.8%
H
1.2
47.0
|
| Axe Compute Inc |
|
95.1
|
8.3
|
L
 -1.0%
H
8.1
8.7
|
L
 -1.6%
H
7.7
8.7
|
L
 18.0%
H
6.6
10
|
L
 47.7%
H
4.2
10
|
L
 -36.6%
H
1.0
32.1
|
L
 -88.5%
H
1.0
74.5
|
L
 -97.3%
H
1.0
439.8
|
L
 -99.9%
H
1.0
20250
|
| Precision Optics Corp Inc |
|
47.9
|
4.4
|
L
 4.3%
H
4.2
4.5
|
L
 3.8%
H
4.1
4.5
|
L
 -8.8%
H
4.1
4.9
|
L
 -8.4%
H
4.1
6.2
|
L
 -7.4%
H
3.6
6.2
|
L
 -26.3%
H
3.5
6.9
|
L
H
3.5
7.9
|
L
H
3.5
7.9
|
| Insulet |
|
9,941.2
|
143.3
|
L
 -2.1%
H
143.0
147.2
|
L
 1.5%
H
138.7
147.2
|
L
 -9.9%
H
126.4
172.9
|
L
 -3.6%
H
126.4
172.9
|
L
 -54.6%
H
126.4
354.9
|
L
 -36.0%
H
125.8
354.9
|
L
 -50.2%
H
125.8
354.9
|
L
 233.4%
H
30.7
354.9
|
| Procept BioRobotics Corp |
|
1,240.0
|
21.7
|
L
 -1.4%
H
21.4
22.1
|
L
 6.1%
H
20.8
22.9
|
L
 12.1%
H
16.7
22.9
|
L
 -17.9%
H
16.7
29.7
|
L
 -46.0%
H
16.7
42.7
|
L
 -33.5%
H
16.7
103.8
|
L
H
15.4
103.8
|
L
H
15.4
103.8
|
| Profound Medical Corp |
|
240.9
|
6.6
|
L
 -0.6%
H
6.6
6.8
|
L
 -10.5%
H
6.6
7.6
|
L
 -6.6%
H
6.6
8.5
|
L
 -7.9%
H
6.3
8.5
|
L
 19.7%
H
3.8
9.0
|
L
 -31.2%
H
3.8
11.7
|
L
 -56.5%
H
3.1
16.3
|
L
 -40.7%
H
0.0
29.0
|
| QuidelOrtho Corporation |
|
980.6
|
14.3
|
L
 -5.2%
H
14.1
15.3
|
L
 16.5%
H
12.1
15.5
|
L
 -19.0%
H
11.4
19.0
|
L
 25.6%
H
10.3
19.8
|
L
 -44.9%
H
9.9
35.6
|
L
 -81.3%
H
9.9
84.6
|
L
 -88.3%
H
9.9
180.1
|
L
 -36.0%
H
9.9
306.7
|
| Quanterix Corp |
|
122.5
|
2.6
|
L
 -9.4%
H
2.6
2.9
|
L
 -35.7%
H
2.2
3.1
|
L
 -36.5%
H
2.2
4.4
|
L
 -6.5%
H
2.2
4.6
|
L
 -43.0%
H
2.2
8.8
|
L
 -89.8%
H
2.2
29.7
|
L
 -94.7%
H
2.2
60.9
|
L
H
2.2
92.6
|
| AVITA Medical Inc |
|
242.8
|
7.9
|
L
 -2%
H
7.7
8.2
|
L
 1.0%
H
7.4
8.6
|
L
 95.3%
H
4.0
8.6
|
L
 80.1%
H
3.7
8.6
|
L
 35.3%
H
3.2
8.6
|
L
 -57.1%
H
3.2
18.9
|
L
 -54.9%
H
3.2
21.7
|
L
 12.9%
H
3.2
55.4
|
| Rosecliff Acq Corp I (Class A) |
|
-
|
1.7
|
L
 -2.9%
H
1.7
1.8
|
L
 -4%
H
1.5
1.8
|
L
 0.6%
H
1.5
1.8
|
L
 -21.1%
H
1.5
3.0
|
L
 -20%
H
1.2
3.0
|
L
 -84.7%
H
1.2
19.5
|
L
 -82.6%
H
1.2
19.5
|
L
H
1.2
19.5
|
| Rockwell Medical Inc |
|
29.2
|
7.4
|
L
 -5.2%
H
7.4
7.7
|
L
 3.8%
H
6.6
8.0
|
L
 31.6%
H
5.6
8.0
|
L
 -7.0%
H
4.9
8.4
|
L
 -29.4%
H
4.9
21
|
L
 -74%
H
4.9
51.5
|
L
 -89.7%
H
4.9
77
|
L
 -99.1%
H
4.9
987.8
|
| Vyome Holdings Inc |
|
15.3
|
2.2
|
L
 0.9%
H
2.1
2.2
|
L
 0.9%
H
2.1
2.3
|
L
H
2.0
2.3
|
L
 13.5%
H
1.8
2.5
|
L
 -84.4%
H
1.8
12.9
|
L
 -96.7%
H
0.3
74.8
|
L
 -100.0%
H
0.3
11716
|
L
H
0.3
1381560
|
| Rewalk Robotics Ltd |
|
447.8
|
7.5
|
L
 -5.7%
H
7.2
8.0
|
L
 -3.0%
H
7.2
8
|
L
 -6.9%
H
6.8
8.3
|
L
 12.9%
H
6
9.6
|
L
 1121.3%
H
0.4
9.6
|
L
 57.2%
H
0.4
9.6
|
L
 -25.1%
H
0.4
19.5
|
L
 -99.4%
H
0.4
1165.5
|
| Sight Sciences Inc |
|
448.4
|
8.1
|
L
 -2.2%
H
8.1
8.5
|
L
 9.0%
H
7.5
8.6
|
L
 61.2%
H
4.4
8.6
|
L
 56.5%
H
4.2
8.6
|
L
 91.5%
H
3.2
9.2
|
L
 6.8%
H
1.0
9.2
|
L
 -77.0%
H
1.0
39.7
|
L
H
1.0
42.6
|
| Sotera Health Co |
|
5,390.7
|
18.9
|
L
 -0.7%
H
18.8
19.0
|
L
 0.2%
H
18.6
19.3
|
L
 6.3%
H
16.8
19.8
|
L
 22.0%
H
14.8
19.8
|
L
 19.9%
H
13.1
19.9
|
L
 12.2%
H
9.5
19.9
|
L
 -22.6%
H
5.8
27.4
|
L
H
5.8
30.4
|
| SI-BONE Inc |
|
848.4
|
18.9
|
L
 -0.1%
H
18.7
19.1
|
L
 1.7%
H
18.4
19.3
|
L
 12.0%
H
16.3
19.4
|
L
 29.7%
H
13.4
19.4
|
L
 23.7%
H
11.5
21.9
|
L
 -11.1%
H
11.5
23.3
|
L
 -9.8%
H
11.1
29.5
|
L
H
7.2
37.2
|
| SINTX Tech Inc |
|
8.0
|
1.6
|
L
 -4.1%
H
1.6
1.7
|
L
 -1.2%
H
1.5
1.8
|
L
 5.1%
H
1.4
1.9
|
L
 -31.7%
H
1.4
2.5
|
L
 -46.2%
H
1.4
6.8
|
L
 -99.3%
H
0.1
252
|
L
 -100.0%
H
0.1
30200
|
L
 -100.0%
H
0.1
10080000
|
| Beauty Health Co (Class A) |
|
87.2
|
0.7
|
L
 1.5%
H
0.6
0.7
|
L
 1.5%
H
0.6
0.7
|
L
 -22.1%
H
0.6
0.9
|
L
 -1.5%
H
0.6
1.2
|
L
 -69.1%
H
0.6
2.7
|
L
 -89.8%
H
0.6
7.2
|
L
 -97.1%
H
0.6
30.2
|
L
H
0.6
30.2
|
| Sanara MedTech Inc |
|
313.8
|
34.2
|
L
 0.0%
H
34.1
34.2
|
L
 0.2%
H
33.7
34.4
|
L
 45.6%
H
23.4
34.4
|
L
 57.8%
H
20.4
34.4
|
L
 12.3%
H
16.1
36.0
|
L
 -23.4%
H
16.1
43.9
|
L
 -5.1%
H
16.1
50.2
|
L
 499.1%
H
2
75
|
| Sensus Healthcare Inc |
|
47.1
|
2.9
|
L
 -9.5%
H
2.8
3.0
|
L
 -6.8%
H
2.8
3.3
|
L
 -7.1%
H
2.8
3.3
|
L
 -20.8%
H
2.7
3.7
|
L
 -16.9%
H
2.7
5.5
|
L
 -17.8%
H
1.8
9.3
|
L
 -18.3%
H
1.8
15.3
|
L
 -56%
H
1.8
15.3
|
| Staar Surgical Co. |
|
1,312.8
|
26.2
|
L
 3.4%
H
24.8
26.2
|
L
 8.1%
H
23.3
26.2
|
L
 -4.2%
H
21.2
29.9
|
L
 -18.2%
H
21.2
33.9
|
L
 -8.4%
H
15.6
35.9
|
L
 -38.2%
H
13.5
52.7
|
L
 -81.2%
H
13.5
163.1
|
L
 194.5%
H
7.5
163.1
|
| Neuronetics Inc |
|
229.6
|
3.3
|
L
 8.9%
H
3.0
3.3
|
L
 38.7%
H
2.0
3.4
|
L
 86.4%
H
1.6
3.4
|
L
 153.9%
H
1.1
3.4
|
L
 -7.3%
H
0.8
3.8
|
L
 89.7%
H
0.5
5.9
|
L
 -61.0%
H
0.5
8.9
|
L
H
0.5
39.4
|
| SkyAI Inc |
|
42.1
|
1.0
|
L
 -2%
H
1.0
1.0
|
L
 -19.0%
H
1.0
1.3
|
L
 -15.5%
H
1.0
1.5
|
L
 -51%
H
0.9
2.0
|
L
 -80.9%
H
0.9
18.2
|
L
 -100.0%
H
0.0
5965.7
|
L
H
0.0
23892
|
L
H
0.0
23892
|
| Tactile Systems Tech Inc |
|
548.2
|
24.2
|
L
 2.1%
H
23.3
24.3
|
L
 -18.0%
H
23
30.2
|
L
 -12.4%
H
23
30.4
|
L
 5.0%
H
22.5
32.4
|
L
 95.5%
H
12.3
37.8
|
L
 27.8%
H
8.6
37.8
|
L
 -41.2%
H
6.3
46.4
|
L
 74.4%
H
6.3
76.6
|
| TELA Bio Inc |
|
28.7
|
0.6
|
L
 -5.9%
H
0.6
0.7
|
L
 -26.4%
H
0.6
1
|
L
 -14.7%
H
0.6
1
|
L
 -35.4%
H
0.6
1.0
|
L
 -60%
H
0.5
1.9
|
L
 -93.0%
H
0.5
9.9
|
L
 -95.3%
H
0.5
14.9
|
L
H
0.5
23.5
|
| Valion Bio Inc |
|
0.8
|
0.2
|
L
 11.8%
H
0.2
0.3
|
L
 -32.1%
H
0.2
1.3
|
L
 -59.6%
H
0.2
1.3
|
L
 -79.6%
H
0.2
1.3
|
L
 -94.6%
H
0.2
5.6
|
L
 -99.7%
H
0.2
194.8
|
L
H
0.2
11050
|
L
H
0.2
11050
|
| Treace Medical Concepts Inc |
|
311.5
|
4.8
|
L
 6.2%
H
4.5
4.8
|
L
 0.6%
H
4.4
4.9
|
L
 7.9%
H
3.9
5.2
|
L
 72.9%
H
2.5
5.2
|
L
 -31.1%
H
1.2
7.8
|
L
 -72.2%
H
1.2
17.6
|
L
 -80.2%
H
1.2
31.0
|
L
H
1.2
37.2
|
| Transmedics Grp Inc |
|
3,071.5
|
88.6
|
L
 -1.2%
H
87.8
90.1
|
L
 5.6%
H
81.8
90.1
|
L
 18.8%
H
68
90.1
|
L
 42.8%
H
61.4
90.1
|
L
 -31.7%
H
60.1
156
|
L
 41.5%
H
36.4
177.4
|
L
 204.8%
H
10
177.4
|
L
H
10
177.4
|
| Tandem Diabetes Care Inc |
|
1,580.8
|
22.7
|
L
 -1.8%
H
22.4
22.9
|
L
 1.5%
H
21.8
23.8
|
L
 46.2%
H
15.1
23.8
|
L
 60.6%
H
12.3
23.8
|
L
 113.1%
H
10.3
29.7
|
L
 -21.2%
H
10.0
53.7
|
L
 -78.8%
H
10.0
155.9
|
L
 -64.6%
H
2.1
155.9
|
| Trinity Biotech PLC (ADR) |
|
7.9
|
11.7
|
L
 -1.7%
H
11.5
13.0
|
L
 -6.1%
H
11.3
13.9
|
L
 14.4%
H
7.9
14.2
|
L
 -33.4%
H
7.9
22.5
|
L
 -99.2%
H
7.9
1477.5
|
L
 -99.9%
H
7.9
17212.5
|
L
 -100.0%
H
7.9
57187.5
|
L
 -100.0%
H
7.9
256500
|
| Utah Medical Products Inc |
|
226.1
|
71
|
L
 -1.5%
H
70.6
72.6
|
L
 0.2%
H
70.1
72.7
|
L
 4.0%
H
63.8
75.0
|
L
 11.5%
H
62.6
75.8
|
L
 24.9%
H
53.7
75.8
|
L
 -26.2%
H
51.3
96.5
|
L
 -17.8%
H
51.3
133.9
|
L
 11.5%
H
51.3
133.9
|
| Vivani Medical Inc |
|
121.9
|
1.4
|
L
 4.5%
H
1.3
1.4
|
L
 -0.7%
H
1.3
1.4
|
L
H
1.2
1.5
|
L
 16.7%
H
1.1
1.7
|
L
 10.2%
H
0.9
1.9
|
L
 14.8%
H
0.8
7.8
|
L
 -87.2%
H
0.8
12.7
|
L
 -98.5%
H
0.8
94.1
|
| Veracyte Inc |
|
3,316.1
|
41.3
|
L
 -3.2%
H
41
43.1
|
L
 -12.6%
H
41
47.8
|
L
 -27.2%
H
41
60.8
|
L
 6.0%
H
37.7
60.9
|
L
 37.3%
H
28.3
60.9
|
L
 62.7%
H
18.6
60.9
|
L
 1.7%
H
14.9
60.9
|
L
 716.8%
H
5.0
86.0
|
| Varex Imaging Corp |
|
779.3
|
18.5
|
L
 -0.1%
H
18.5
18.5
|
L
 49.0%
H
18.4
18.6
|
L
 74.9%
H
10.0
18.6
|
L
 84.5%
H
9.3
18.6
|
L
 71.5%
H
9.1
18.6
|
L
 -10.6%
H
6.8
21.5
|
L
 -33.0%
H
6.8
32.7
|
L
H
6.8
43.8
|
| Vivos Therapeutics Inc |
|
4.7
|
0.3
|
L
 13.3%
H
0.3
0.4
|
L
 6.3%
H
0.3
0.4
|
L
 -17.1%
H
0.3
0.5
|
L
 -50.7%
H
0.3
1.4
|
L
 -92.6%
H
0.3
4.9
|
L
 -96.0%
H
0.3
48.8
|
L
 -99.6%
H
0.3
177.3
|
L
H
0.3
360.3
|
| Wrap Tech Inc |
|
105.3
|
1.9
|
L
 8.1%
H
1.7
1.9
|
L
 0.5%
H
1.7
2.0
|
L
 -14.2%
H
1.6
2.4
|
L
 13.9%
H
1.0
2.7
|
L
 24.5%
H
1.0
3.2
|
L
 15.3%
H
1.0
7.0
|
L
 -75.8%
H
1.0
7.8
|
L
H
1.0
14.4
|
| Beyond Air Inc |
|
5.6
|
6.3
|
L
 -8.7%
H
6.2
7
|
L
 17.9%
H
5.1
7.2
|
L
 9.5%
H
5.0
7.7
|
L
 -32.8%
H
5.0
10.5
|
L
 -86.4%
H
5.0
95.6
|
L
 -99.6%
H
5.0
1440
|
L
 -99.8%
H
5.0
6564
|
L
H
5.0
18000
|
| DENTSPLY Sirona Inc |
|
2,310.5
|
11.6
|
L
 0.1%
H
11.5
11.9
|
L
 -4.4%
H
11.2
12.1
|
L
 -8.7%
H
11.2
14.4
|
L
 11.3%
H
9.4
14.4
|
L
 -16.4%
H
9.4
14.9
|
L
 -69.7%
H
9.4
38.4
|
L
 -80.3%
H
9.4
63.1
|
L
 -81.0%
H
9.4
69.5
|
| X.T.L. Biopharma Ltd (ADR) |
|
6.8
|
2.8
|
L
 -0.7%
H
2.6
3.0
|
L
 -5.4%
H
2.6
3.0
|
L
 -6.1%
H
2.5
3.0
|
L
 3.0%
H
2.0
3.4
|
L
 -87.8%
H
2.0
41.1
|
L
 -79.3%
H
2.0
79.8
|
L
 -95.1%
H
2.0
90.4
|
L
 -96.9%
H
2.0
107.0
|
| Jin Medical Intl Ltd |
|
26.5
|
3.4
|
L
 3.7%
H
3.2
3.6
|
L
 57.2%
H
2.5
3.7
|
L
 72.5%
H
1.5
3.7
|
L
 37.4%
H
1.5
4.5
|
L
 -73.3%
H
1.5
17.2
|
L
 -68.3%
H
1.5
509.9
|
L
H
1.5
509.9
|
L
H
1.5
509.9
|
| HeartBeam Inc |
|
28.2
|
0.5
|
L
 -15.3%
H
0.5
0.6
|
L
 -3.9%
H
0.5
0.6
|
L
 -10.7%
H
0.5
0.7
|
L
 -51.9%
H
0.5
1.0
|
L
 -55.0%
H
0.5
4
|
L
 -68.4%
H
0.5
4
|
L
 -68.4%
H
0.5
4
|
L
 -68.4%
H
0.5
4
|
| TriSalus Life Sciences Inc |
|
324.5
|
5.3
|
L
 -6.4%
H
5.2
5.6
|
L
 -6.1%
H
5.2
5.9
|
L
 30.5%
H
4.0
5.9
|
L
 109.1%
H
2.4
5.9
|
L
 35.8%
H
2.2
8.0
|
L
 -22.2%
H
2.2
10.4
|
L
 -22.2%
H
2.2
10.4
|
L
 -22.2%
H
2.2
10.4
|
| Spectral AI Inc (Class A) |
|
54.1
|
1.7
|
L
 -2.9%
H
1.7
1.8
|
L
 -4%
H
1.5
1.8
|
L
 0.6%
H
1.5
1.8
|
L
 -21.1%
H
1.5
3.0
|
L
 -20%
H
1.2
3.0
|
L
H
0.8
13
|
L
H
0.8
13
|
L
H
0.8
13
|
| Envoy Medical Inc (Class A) |
|
61.8
|
0.8
|
L
 6.7%
H
0.7
0.8
|
L
 19.4%
H
0.7
0.8
|
L
 5.3%
H
0.6
0.8
|
L
 21.2%
H
0.6
0.9
|
L
 -45.2%
H
0.4
1.9
|
L
H
0.4
11.5
|
L
H
0.4
11.5
|
L
H
0.4
11.5
|
| Autonomix Medical Inc |
|
3.7
|
6.9
|
L
 -0.2%
H
6.3
7
|
L
 -31.8%
H
6.3
9.8
|
L
 32.0%
H
2.4
24.7
|
L
 1.3%
H
2.4
24.7
|
L
 -71.1%
H
2.4
32.6
|
L
H
2.4
3192
|
L
H
2.4
3192
|
L
H
2.4
3192
|
| Rewalk Robotics Ltd |
|
21.0
|
7.5
|
L
 -5.7%
H
7.2
8.0
|
L
 -3.0%
H
7.2
8
|
L
 -6.9%
H
6.8
8.3
|
L
 12.9%
H
6
9.6
|
L
 1.5%
H
4.1
10.6
|
L
 -86.9%
H
4.1
109.2
|
L
 -93.8%
H
4.1
233.5
|
L
 -99.9%
H
4.1
13986
|
| GRAIL Inc |
|
3,031.5
|
67.9
|
L
 -0.5%
H
66.4
68.7
|
L
 -2.3%
H
66.4
76.4
|
L
 -7.2%
H
60.8
76.4
|
L
 9.8%
H
54.5
79.5
|
L
 110.9%
H
30.0
118.8
|
L
H
12.6
118.8
|
L
H
12.6
118.8
|
L
H
12.6
118.8
|
| Work Medical Tech Grp Ltd |
|
5.4
|
2.2
|
L
 6.2%
H
2.1
2.3
|
L
 4.7%
H
1.9
2.7
|
L
 12.1%
H
1.8
2.7
|
L
 -98.3%
H
1.8
106
|
L
 -100%
H
1.8
930000
|
L
H
1.8
8446000
|
L
H
1.8
8446000
|
L
H
1.8
8446000
|
| iTonic Holdings Ordinary |
|
5.3
|
0.3
|
L
 6.9%
H
0.3
0.4
|
L
 6.9%
H
0.3
0.4
|
L
 -6.1%
H
0.2
0.4
|
L
H
0.2
1.2
|
L
 -53.7%
H
0.2
1.2
|
L
H
0.2
32
|
L
H
0.2
32
|
L
H
0.2
32
|
| Ceribell Inc |
|
895.4
|
23.3
|
L
 0.3%
H
23.0
23.6
|
L
 24.0%
H
18.6
23.6
|
L
 22.0%
H
16.0
23.6
|
L
 41.7%
H
16.0
23.6
|
L
 97.9%
H
10.9
24.3
|
L
H
10.0
32.8
|
L
H
10.0
32.8
|
L
H
10.0
32.8
|
| Anteris Tech Global Corp |
|
916.1
|
9.4
|
L
 5.3%
H
8.7
9.4
|
L
 5.5%
H
8.6
9.5
|
L
 5.0%
H
7.7
9.5
|
L
 29.7%
H
6.9
11.1
|
L
 139.8%
H
3.3
11.1
|
L
H
2.3
11.1
|
L
H
2.3
11.1
|
L
H
2.3
11.1
|
| Beta Bionics Inc |
|
790.5
|
17.6
|
L
 -2.8%
H
17.5
18.2
|
L
 10.5%
H
15.6
18.3
|
L
 4.2%
H
12.7
18.3
|
L
 91.0%
H
9.0
18.3
|
L
 5.2%
H
8.8
32.7
|
L
H
8.8
32.7
|
L
H
8.8
32.7
|
L
H
8.8
32.7
|
| Anbio biotech (Class A) |
|
383.6
|
8.7
|
L
 -14.8%
H
8.4
11
|
L
 -17.6%
H
8.4
11.4
|
L
 -8.1%
H
8.4
13.1
|
L
 -65.1%
H
8.3
36.1
|
L
 -82.6%
H
8.3
55.0
|
L
H
5.2
55.7
|
L
H
5.2
55.7
|
L
H
5.2
55.7
|
| Kestra Medical Tech Ltd |
|
1,642.1
|
28.0
|
L
 1.0%
H
26.5
28.2
|
L
 6.1%
H
26.5
28.8
|
L
 15.9%
H
20.4
28.8
|
L
 27.0%
H
17.9
28.8
|
L
 75.6%
H
15.4
30
|
L
H
13.3
30
|
L
H
13.3
30
|
L
H
13.3
30
|
| Sanuwave Health Inc |
|
40.8
|
4.7
|
L
 -0.6%
H
4.7
5.1
|
L
 -19.4%
H
4.7
6.0
|
L
 -60.4%
H
4.7
10.7
|
L
 -72.2%
H
4.7
17.5
|
L
 -87.5%
H
4.7
45.3
|
L
 -85.3%
H
4.7
46.6
|
L
 -85.3%
H
4.7
46.6
|
L
 -85.3%
H
4.7
46.6
|
| SS Innovations Intl Inc |
|
814.7
|
3.9
|
L
 1.6%
H
3.8
4
|
L
 3.2%
H
3.6
4
|
L
 6.0%
H
3.4
4.2
|
L
 -2.5%
H
3.2
4.4
|
L
 -42.4%
H
3.1
10
|
L
H
3.0
22.4
|
L
H
3.0
22.4
|
L
H
3.0
22.4
|
| CapsoVision Inc |
|
323.3
|
6.5
|
L
 -4.9%
H
6.1
6.7
|
L
 -9.0%
H
6.1
7
|
L
 1.6%
H
6.1
7.3
|
L
 -11.5%
H
5.6
7.8
|
L
 60.7%
H
3.4
15.4
|
L
 84.6%
H
3.4
15.4
|
L
 84.6%
H
3.4
15.4
|
L
 84.6%
H
3.4
15.4
|
| Medline Inc Ordinary Shares |
|
31,356.5
|
35.7
|
L
 0.5%
H
35.5
36.2
|
L
 1.5%
H
33.1
36.2
|
L
 -7.6%
H
33.1
42.2
|
L
 -8.1%
H
32.8
43.6
|
L
 -12.8%
H
32.8
50.9
|
L
 -12.8%
H
32.8
50.9
|
L
 -12.8%
H
32.8
50.9
|
L
 -12.8%
H
32.8
50.9
|
| MiniMed Group Inc |
|
5,659.0
|
20.2
|
L
 0.7%
H
19.8
20.4
|
L
 2.8%
H
19.1
20.9
|
L
 34.0%
H
15.0
20.9
|
L
 81.9%
H
10.7
20.9
|
L
H
10.7
20.9
|
L
H
10.7
20.9
|
L
H
10.7
20.9
|
L
H
10.7
20.9
|
| Mobia Medical Inc |
|
391.0
|
11.8
|
L
 0.7%
H
11.3
12.5
|
L
 -3.9%
H
11.3
13.9
|
L
 1.6%
H
10.3
13.9
|
L
 -2.4%
H
10.3
15.3
|
L
 0.1%
H
10.3
15.3
|
L
 0.1%
H
10.3
15.3
|
L
 0.1%
H
10.3
15.3
|
L
 0.1%
H
10.3
15.3
|
| FocalTherics ADR |
|
178.6
|
4.8
|
L
 2.8%
H
4.5
4.8
|
L
 -23.5%
H
4.5
6.3
|
L
 -12.2%
H
4.5
6.4
|
L
 4.4%
H
4.5
6.4
|
L
 4.4%
H
4.5
6.4
|
L
 4.4%
H
4.5
6.4
|
L
 4.4%
H
4.5
6.4
|
L
 4.4%
H
4.5
6.4
|